Description
Liraglutide is a GLP-1 receptor agonist developed to support blood sugar regulation, appetite control, and sustainable weight management. By mimicking the body’s natural GLP-1 hormone, Liraglutide helps slow gastric emptying, reduce hunger signals, and improve insulin response following meals.
Administered through subcutaneous injection, Liraglutide has been widely studied for its ability to support gradual and consistent fat loss while promoting better metabolic health. In addition to weight management benefits, it may also contribute to improved glucose control and reduced cardiovascular risk factors in certain individuals.







There are no reviews yet.